Purchase Order 36C26219P0601
- Not listed
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $1,283,466.63 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for patient-specific chemotherapy compounding services. Avella, a subsidiary of UnitedHealth Group Incorporated, will provide specialized pharmacy services to support VA oncology and infusion treatment programs nationwide. The award is not associated with a set-aside designation. Avella has...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $187,606.76 Firm Fixed Price Purchase Order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the emergency mixing of chemotherapy compounds to support VA oncology and infusion treatment programs nationwide. Avella will perform the work at its own facilities while partnering with various VA Veterans Integrated Service...
- This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for the provision of custom dosed chemotherapy intravenous (IV) medications to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $132,504.84 firm fixed price purchase order has a period of performance through June 30, 2024. Avella Specialty Pharmacy is a subsidiary of UnitedHealth Group Incorporated and operates as a 503A certified pharmacy, specializing...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Firm Fixed Price Purchase Order worth $148,010.43 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the provision of chemotherapy medication to support VA oncology and infusion treatment programs nationwide. The award does not have a set-aside designation. Optum Pharmacy 801, Inc. has received numerous federal contract...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Blanket Purchase Agreement (BPA) call to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. This BPA call, valued at $500,000.00, is for the renewal of a contract to provide chemotherapy compounding services over a one-year period of performance ending on November 16, 2023. Avella will perform the work at its own facilities to support VA...
- Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, has been awarded a $44,809.12 firm-fixed-price purchase order by the Department of Veterans Affairs' Veterans Health Administration Veterans Integrated Service Network 5 to provide custom dosed chemotherapy intravenous medications. As the prime contractor, Avella will compound customized chemotherapy and other hazardous sterile preparations based on patient-specific orders from the VA medical center in Phoenix, Arizona, to...
- This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) is for chemotherapy compounding services for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $97,052.49 and a performance period running through November 16, 2024. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy agents, hazardous sterile preparations,...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $1,875,405.34 contract is for the provision of compounded chemotherapy drugs to support VA oncology and infusion treatment programs at the VA Long Beach Healthcare System in California. The contract period of performance is April 2, 2019 to...
- This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for medication compounding services provided to the Department of Veterans Affairs Veterans Health Administration (VA-VHA). The $424,949.34 firm fixed-price purchase order was awarded on March 4, 2018, with a completion date of May 31, 2018. Avella, a subsidiary of UnitedHealth Group, has received numerous VA-VHA awards for specialized pharmacy services involving chemotherapy and hazardous...
- This federal contract award, valued at $230,297.50, was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the delivery of sterile compound supply services to support VA oncology and infusion treatment programs nationwide. As the prime contractor, Avella Specialty Pharmacy will compound customized chemotherapy and other...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $699,995.00 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the provision of emergency compounded chemotherapy drugs. The period of performance was from February 1, 2019 to April 30, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, has received numerous VA-VHA awards to provide specialized pharmacy services involving chemotherapy and hazardous drug compounding. The contract had no set-aside designation. Avella compounds customized chemotherapy and other hazardous sterile preparations based on patient-specific orders to support VA oncology and infusion treatment programs nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $700.0k | 1/23/19 |